Search
Search Results
##search.searchResults.foundPlural##
-
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2146PDF: 169HTML: 46 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3954PDF: 1584HTML: 358 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1677PDF: 983HTML: 2259Response to reviewers comments: 236 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2560PDF: 881HTML: 487 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
922PDF: 522HTML: 1318 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9442PDF: 6275HTML: 88254Fig.1b: 272Fig.1c: 272Fig.2a: 267Fig.2b: 257Fig.4: 282Fig.2c: 253Fig.3: 257Tab.1: 318Tab.2: 295Tab.3: 285Tab.4: 320Fig1a: 269 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2011PDF: 1242HTML: 349 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2714PDF: 942HTML: 17608Fig1 Caligaris: 237Fig.2 Caliga: 275 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1223PDF: 587HTML: 397 -
-
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2971PDF: 1022HTML: 654 -
Takayasu Arteritis Initially Mimicking Infective Endocarditis
1429PDF: 650HTML: 1122 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1398PDF: 949HTML: 1206Coverletter: 295 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
1010PDF: 733Suppl. Files: 154HTML: 185 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1401PDF: 1146HTML: 271 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3592PDF: 1369HTML: 2402Fi.1 Gritti.Rambaldi: 262 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2324PDF: 1056HTML: 1993 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
604PDF: 303HTML: 148 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1431PDF: 646HTML: 4198 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2307PDF: 1673HTML: 706 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3474PDF: 1656HTML: 294 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3040PDF: 1356HTML: 2844Figure 1: 224 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2310PDF: 571HTML: 188 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3917PDF: 1719HTML: 105 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1727PDF: 845HTML: 1342 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1308PDF: 657HTML: 2918ATRA induced Reactive Hemophagocytosis: A Case Report: 244 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1125PDF: 531HTML: 169 -
-
FIRST-PHASE INSULIN RESPONSE (FPIR) TO INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT), INSULIN SENSITIVITY AND LONG-TERM FOLLOW-UP IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT) NORMOGLYCEMIC PATIENTS WITH REDUCED INSULIN SECRETION TO ORAL GLUCOSE TOLERANCE TEST: A PILOT STUDY. The function of the endocrine pancreas in transfusion-dependent ?-thalassemia
7613PDF: 654HTML: 369







